Focusfreda secures patent for retinyl hyaluronic acid sodium, pioneering a gentle yet effective skincare solution
Recently, Focusfreda and Shandong Academy of Pharmaceutical Sciences jointly developed a core technology achievement titled "A Retinoic Acid Hyaluronic Acid Sodium and Its Composition" (ZL202411907798.8), which has been officially authorized by the National Intellectual Property Administration. This marks another significant technological breakthrough for Focusfreda in the field of "hyaluronic acid+" functional ingredient research, signaling a crucial step forward in the company's innovation and application of active ingredients.
As the core innovation of this patent, retinoic acid hyaluronic acid sodium achieves precise molecular design by grafting retinoic acid and isorretinoic acid in specific ratios onto the hyaluronic acid matrix. This breakthrough ingeniously combines the superior moisturizing and repair capabilities of hyaluronic acid with the multifunctional benefits of retinoic acid. The formulation not only effectively addresses traditional limitations of retinoic acid—poor water solubility, low stability, and skin irritation—but also synergistically enhances oil control, acne treatment, anti-aging, and skin brightening effects. This represents a groundbreaking raw material solution for developing gentle yet highly effective functional skincare products.
The patented technology optimizes the formulation ratio and stability of active ingredients. By precisely controlling the grafting ratio and esterification degree of two retinoids, it achieves optimal efficacy balance. The innovative polyol complexation technology further ensures stable composition. Experimental data confirms this approach effectively delays ingredient degradation, significantly enhances raw material storage stability and product applicability, thereby establishing a robust foundation for subsequent end-product development.
Focusfreda has consistently prioritized its "hyaluronic acid+" strategic roadmap, with this patent authorization representing a pivotal breakthrough in active ingredient innovation and application. Going forward, the company will accelerate the industrialization of this technology across premium skincare, personal care, and dermatological treatments. It will develop a diverse range of products including serums, lotions, creams, and acne-targeting gels, injecting cutting-edge technological advancements to propel the high-quality development of the health and beauty industry.
RECOMMENDED READING
CONTACT US
Tel：+86-0537-3195566
E-mail：sales@focuschem.com
Add：Economic Development Zone, High-speed Railway New District, Qufu City, Jining City, Shandong Province, China
Copyright © 2022 Shandong Focusfreda Biotech Co., Ltd. 鲁ICP备2021008509号-2 Powerby : 300.cn jinan SEO